Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial-Reference-Cited by-同舟云学术

Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial

Published:2014-06-04 Issue:26 Volume:35 Page:1752-1759
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Esler Murray D.¹,Böhm Michael²,Sievert Horst³,Rump Christian L.⁴,Schmieder Roland E.⁵,Krum Henry⁶,Mahfoud Felix²,Schlaich Markus P.¹

Affiliation:

1. Baker IDI Heart and Diabetes Institute, Monash University, 75 Commercial Road, Melbourne, Victoria 3004, Australia

2. Universitätsklinium des Saarlandes, Homburg/Saar, Germany

3. CardioVaskuläres Centrum, Frankfurt, Germany

4. Department of Nephrology, Heinrich-Heine-University, Medical Faculty, Düsseldorf, Germany

5. Department of Nephrology, Hypertension of the University Hospital, Clinical Research Competence Center of Hypertension and Vascular Medicine, Erlangen, Germany

6. Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

Funder

NIH

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/35/26/1752/25024284/ehu209.pdf

Reference31 articles.

1. Global burden of hypertension: analysis of worldwide data;Kearney;Lancet,2005

2. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis;Franco;Hypertension,2005

3. Selected major risk factors and global and regional burden of disease;Ezzati;Lancet,2002